Edward J. Dulac III, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 14,924 shares at $14.02 ($209K) on 2025-07-23, disclosed to the SEC on 2025-07-25.
Open-market sale of $209k NTLA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.02 | 7,462 | $105K | 50.0% |
| 2 | $14.02 | 7,462 | $105K | 50.0% |
| Total | $14.02 avg | 14,924 | $209K | 100% |
| Filing → |
| NTLA | SELL | 2026-01-07 | $59K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |
| FATE | SELL | 2024-01-30 | $9K | — | Filing → |